Longitudinal impact of temporary mechanical circulatory support on durable ventricular assist device outcomes: An IMACS registry propensity matched analysis.

[1]  J. Bauersachs,et al.  Mortality in patients with cardiogenic shock treated with the Impella CP microaxial pump for isolated left ventricular failure , 2020, European heart journal. Acute cardiovascular care.

[2]  H. Thiele,et al.  Response by Schrage et al to Letter Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis". , 2019, Circulation.

[3]  J. Rogers,et al.  Risk Assessment in Patients with a Left Ventricular Assist Device Across INTERMACS Profiles Using Bayesian Analysis. , 2019, ASAIO journal.

[4]  J. Ornato,et al.  SCAI clinical expert consensus statement on the classification of cardiogenic shock , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[5]  Michael V. Green,et al.  Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6]  S. Blankenberg,et al.  Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis , 2019, Circulation.

[7]  A. Kirtane,et al.  Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock. , 2019, Journal of the American College of Cardiology.

[8]  R. Higgins,et al.  The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships. , 2019, The Annals of thoracic surgery.

[9]  B. Gersh,et al.  Trends, Predictors, and Outcomes of Temporary Mechanical Circulatory Support for Postcardiac Surgery Cardiogenic Shock. , 2019, The American journal of cardiology.

[10]  M. Mori,et al.  Improving Outcomes in INTERMACS 1 Category 1 Patients with Pre-LVAD, Awake Venous-Arterial Extracorporeal Membrane Oxygenation Support. , 2019, ASAIO journal.

[11]  J. Hernandez-Montfort,et al.  Personalizing care in cardiogenic shock: Searching for a common hemodynamic language. , 2019, Heart & lung : the journal of critical care.

[12]  B. Gersh,et al.  Temporary Mechanical Circulatory Support for Refractory Cardiogenic Shock Before Left Ventricular Assist Device Surgery , 2018, Journal of the American Heart Association.

[13]  M. Ragosta,et al.  Outcomes of patients with cardiogenic shock treated with TandemHeart® percutaneous ventricular assist device: Importance of support indication and definitive therapies as determinants of prognosis , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  D. Burkhoff,et al.  Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  W. O’Neill,et al.  Cardiac Shock Care Centers: JACC Review Topic of the Week. , 2018, Journal of the American College of Cardiology.

[16]  P. Lawler,et al.  Advancing from a "hemodynamic model" to a "mechanistic disease-modifying model" of cardiogenic shock. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  D. Burkhoff,et al.  Mechanical Unloading in Heart Failure. , 2018, Journal of the American College of Cardiology.

[18]  W. Cohn,et al.  Bridging to a Long‐Term Ventricular Assist Device With Short‐Term Mechanical Circulatory Support , 2018, Artificial organs.

[19]  Takeshi Nakatani,et al.  Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  A. Mebazaa,et al.  Management of cardiogenic shock complicating myocardial infarction , 2018, Intensive Care Medicine.

[21]  B. Hammill,et al.  Intra-Aortic Balloon Pump Use Before Left Ventricular Assist Device Implantation: Insights From the INTERMACS Registry , 2018, ASAIO journal.

[22]  N. Kapur,et al.  Timing, timing, timing: the emerging concept of the 'door to support' time for cardiogenic shock. , 2017, European heart journal.

[23]  E. Ohman,et al.  Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association , 2017, Circulation.

[24]  N. Kapur,et al.  Acute mechanical circulatory support for cardiogenic shock: the “door to support” time , 2017, F1000Research.

[25]  E. Ohman,et al.  Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. , 2017, The American journal of cardiology.

[26]  S. Blankenberg,et al.  Concomitant implantation of Impella® on top of veno‐arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock , 2017, European journal of heart failure.

[27]  J. Tijssen,et al.  Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. , 2017, Journal of the American College of Cardiology.

[28]  Takeshi Nakatani,et al.  First Annual IMACS Report: A global International Society for Heart and Lung Transplantation Registry for Mechanical Circulatory Support. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[29]  F. Pagani,et al.  INTERMACS profiles and modifiers: Heterogeneity of patient classification and the impact of modifiers on predicting patient outcome. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  Michael Bailey,et al.  Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. , 2015, European heart journal.

[31]  J. Goldstein,et al.  2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation o , 2015, Journal of the American College of Cardiology.

[32]  J. Goldstein,et al.  2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiología Intervencionista; Affirmat , 2015, Journal of the American College of Cardiology.

[33]  M. Amrani,et al.  Distal limb perfusion: Achilles' heel in peripheral venoarterial extracorporeal membrane oxygenation. , 2014, Artificial organs.

[34]  S. Pinney,et al.  Clinical variability within the INTERMACS 1 profile: implications for treatment options , 2014, Current opinion in cardiology.

[35]  D. Kolte,et al.  Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST‐Elevation Myocardial Infarction in the United States , 2014, Journal of the American Heart Association.

[36]  P. Loyalka,et al.  The percutaneous ventricular assist device in severe refractory cardiogenic shock. , 2011, Journal of the American College of Cardiology.

[37]  M. Simoons,et al.  Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. , 2010, European heart journal.

[38]  Karen Ulisney,et al.  INTERMACS profiles of advanced heart failure: the current picture. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[39]  Pascal Leprince,et al.  Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock* , 2008, Critical care medicine.

[40]  Matthew P. Thomas,et al.  Pharmacological Criteria for Ventricular Assist Device Insertion Following Postcardiotomy Shock: Experience with the Abiomed BVS System , 1999 .

[41]  M. Barnard,et al.  Acute circulatory support. , 1993, BMJ.

[42]  N. Uriel,et al.  Use of a percutaneous temporary circulatory support device as a bridge to decision during acute decompensation of advanced heart failure. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[43]  N. Uriel,et al.  Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[44]  S. Pedersen,et al.  A high-intensity exercise program improves exercise capacity, self-perceived health, anxiety and depression in heart transplant recipients: a randomized, controlled trial. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.